H.R. 6294 · 115th Congress
Re-Valuing Anti-Microbial Products Act of 2018
- Stage
- In committee
- Sponsor
- John Shimkus
- Introduced
- 2018-06-28
- Latest action
- 2018-06-28 · Introduced in House
Subjects
Congressional oversight
Government studies and investigations
Health
Health promotion and preventive care
Infectious and parasitic diseases
Licensing and registrations
Drug therapy
Advisory bodies
Intellectual property
Prescription drugs
Drug safety, medical device, and laboratory regulation